VaneJ.R.. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.Nat New Biol.1971; 231: 232–235.
2.
PortanovaJ.P., ZhangY., AndersonG.D.. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia and interleukin 6 production in vivo.J Exp Med.1996; 184: 883–891.
3.
RazA., WycheA., SiegelN.. Regulation of fibroblast cyclooxygenase synthesis by interleukin-1.J Biol Chem.1988; 263: 3022–3028.
4.
ReingoldD.F., WattersK., HolbergS.. Differential biosynthesis of prostaglandins by hydronephrotic rabbit and cat kidneys.J Pharmacol Exp Ther.1981; 216: 510–515.
5.
O'BanionM.K., SadowskiH.B., WinnV.. A serum and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein.J Biol Chem.1991; 266: 23261–23267.
6.
SmithW.L., DewittD.L.. Prostaglandin endoperoxide H synthases-1 and -2.Adv Immunol.1996; 62: 167–215.
7.
XieW.L., ChipmanJ.G., RobertsonD.L.. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.Proc Natl Acad Sci U S A.1991; 88: 2692–2696.
8.
PicotD., LollP.J., GaravitoR.M.. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1.Nature.1994; 367: 243–249.
9.
YagamataK., AndreassonK.I., KaufmannW.E.. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids.Neuron.1993; 11: 371–386.
10.
CaoC., MatsumuraK., YamagataK.. Induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain: its possible role in the febrile response.Brain Res.1995; 697: 187–196.
11.
JensenB.L., KurtzA.. Differential regulation of renal cyclooxygenase mRNA by dietary salt intake.Kidney Int.1997; 52: 1242–1249.
12.
KomhoffM., GroneH.J., KleinT.. Localization of cycloooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function.Am J Physiol.1997; 272: F460–468.
13.
SanoH., HlaT., MaierJ.A.. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis.J Clin Invest.1992; 89: 97–108.
14.
AndersonG.D., HauserS.D., McGarityK.L.. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis.J Clin Invest.1996; 97: 2672–2679.
15.
SiegleI., KleinT., BackmanJ.T.. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint disease.Arthritis Rheum.1998; 41: 122–129.
16.
MaloneyC.G., KutcheraW.A., AlbertineK.H.. Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils.J Immunol.1998; 160: 1402–1410.
17.
PouliotM., JamesM.J., McCollS.R.. Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes.Blood.1998; 91: 1769–1776.
18.
LaneuvilleO., BreuerD.K., DewittD.L.. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.J Pharm Exp Ther.1994; 271: 927–934.
19.
MeadeE.A., SmithW.L., DeWittD.L.. Differential inhibition of prostaglandin endooeroxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.J Biol Chem.1993; 268: 6610–6614.
20.
GlaserK., SungM.L., O'NeillK.. Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1.Eur J Pharmacol.1995; 281: 107–111.
21.
MitchellJ.A., AkarasereenontP., ThiemermannC.. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.Proc Natl Acad Sci U S A.1993; 90: 11693–11697.
22.
SubbaramaiahK., ZakimD., WekslerB.B.. Inhibition of cyclooxygenase: a novel approach to cancer prevention.Proc Soc Exp Biol Med.1997; 216: 201–210.